购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Antibiotic
    (1)
  • Ferroptosis
    (1)
  • Lipase
    (1)
  • Phospholipase
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (4)
  • 5日内发货
    (5)
  • 35日内发货
    (3)
  • 8-10周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "droplets"的结果
筛选
搜索结果
TargetMol产品目录中 "

droplets

"的结果
  • 抑制剂&激动剂
    13
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    2
    TargetMol | Recombinant_Protein
  • 多肽产品
    1
    TargetMol | Peptide_Products
  • 染料试剂
    11
    TargetMol | Dye_Reagents
  • 天然产物
    3
    TargetMol | Natural_Products
  • 试剂盒
    3
    TargetMol | Reagent_Kits
  • CAY10650
    TQ01051233706-88-1
    CAY10650 是高效的胞浆磷脂酶A2α抑制剂,IC50=12 nM,能够抑制脂滴形成和 PGE2 分泌。
    • ¥ 413
    In stock
    规格
    数量
  • Triacsin C
    三氮菌素 C, WS 1228A, FR 900190
    T1319976896-80-5
    Triacsin C (WS 1228A) 来自金黄色链霉菌 (Streptomyces aureofaciens) ,是一种花生四烯酰辅酶A合成酶和非特异性长链酰辅酶A合成酶的差异抑制剂,抗动脉粥样硬化活性,抑制 ACSL 活性, 抑制 TAG 积聚成脂滴 (LD) 。Triacsin C 可用于研究轮状病毒感染和阿尔茨海默症。
    • 待询
    35日内发货
    规格
    数量
  • Nonaethylene glycol monododecyl ether
    聚醚醇, Polidocanol, Nonaoxyethylene monododecyl ether
    T163353055-99-0
    Nonaethylene glycol monododecyl ether (Polidocanol) 是一种非离子表面活性剂和聚乙二醇清洁剂,可用于蛋白质分离和纯化,以及用于形成初始聚结的 O/W 乳剂液滴。
    • ¥ 99
    待询
    规格
    数量
  • CAR-2
    T2056033030055-40-1
    CAR-2 是一种源于 BODIPY 的光敏剂,能通过靶向内质网 (ER) 和脂滴 (LD) 在光动力疗法 (PDT) 中诱导铁死亡 (ferroptosis)。其在乳腺癌细胞中显示出光毒性,IC50为 0.01-0.02 μM。此外,CAR-2 在 4T1 异种移植小鼠模型中展现了抗肿瘤功效。
    • 待询
    10-14周
    规格
    数量
  • NUV-244
    T207745
    NUV-244 是一种PNPLA3 I148M的降解剂。它通过BFAR介导的泛素蛋白酶体降解,降低脂滴上PNPLA3 I148M的水平。
    • 待询
    规格
    数量
  • NIM-7
    NIM7
    T33674
    NIM-7 is a fluorescent probe, allowing lipid droplets and lysosomes to be labelled simultaneously and with high specificity, being visualized readily through yellow and red fluorescence, using different excitation and detection channels.
    • 待询
    规格
    数量
  • MD001
    T358002254605-76-8
    MD001 is a dual agonist of peroxisome proliferator-activated receptor α (PPARα) and PPARγ.1 It binds to PPARα and PPARγ (Kds = 9.55 and 0.14 μM, respectively) but does not bind to PPARβ/δ at concentrations up to 500 μM. It increases transcriptional activity of PPARα and PPARγ in a cell-based luciferase reporter assay when used at a concentration of 10 μM. MD001 (10 μM) increases expression of PPARα, PPARγ, and retinoid X receptor (RXR), as well as PPARα and PPARγ target genes, in HepG2 cells. It increases glucose consumption as well as expression of GLUT2 and GLUT4 in HepG2 and 3T3-L1 cells, respectively, in a concentration-dependent manner. MD001 (20 mg/kg) decreases levels of glucose, insulin, free fatty acids, triglycerides, LDL, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in blood and reduces the size and number of hepatic lipid droplets in diabetic db/db mice.References1. Kim, S.-H., Hong, S.H., Park, Y.-J., et al. MD001, a novel peroxisome proliferator-activated receptor α/γ agonist, improves glucose and lipid metabolism. Sci. Rep. 9(1), 1656 (2019). MD001 is a dual agonist of peroxisome proliferator-activated receptor α (PPARα) and PPARγ.1 It binds to PPARα and PPARγ (Kds = 9.55 and 0.14 μM, respectively) but does not bind to PPARβ/δ at concentrations up to 500 μM. It increases transcriptional activity of PPARα and PPARγ in a cell-based luciferase reporter assay when used at a concentration of 10 μM. MD001 (10 μM) increases expression of PPARα, PPARγ, and retinoid X receptor (RXR), as well as PPARα and PPARγ target genes, in HepG2 cells. It increases glucose consumption as well as expression of GLUT2 and GLUT4 in HepG2 and 3T3-L1 cells, respectively, in a concentration-dependent manner. MD001 (20 mg/kg) decreases levels of glucose, insulin, free fatty acids, triglycerides, LDL, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in blood and reduces the size and number of hepatic lipid droplets in diabetic db/db mice. References1. Kim, S.-H., Hong, S.H., Park, Y.-J., et al. MD001, a novel peroxisome proliferator-activated receptor α/γ agonist, improves glucose and lipid metabolism. Sci. Rep. 9(1), 1656 (2019).
    • ¥ 10900
    35日内发货
    规格
    数量
  • ML261
    T62029902523-58-4
    ML261 是肝脂滴形成的抑制剂,IC50值为 69.7 nM。ML261 在非酒精性脂肪性肝病 (NAFLD) 和炎症中具有研究价值。
    • ¥ 938
    35日内发货
    规格
    数量
  • ST-148 maleate
    T84698390803-40-4
    ST-148 maleate,一种有效的口服活性DENV抑制剂,具备抗病毒作用且低细胞毒性。它通过改变脂滴与C蛋白之间的相互作用,从而抑制病毒复制。
    • 待询
    8-10周
    规格
    数量
  • E722-2648
    T86330931963-55-2
    E722-2648 是一种有效的 β-catenin BCL9 复合物抑制剂,特异性抑制 β-catenin BCL9 复合物的形成和 Wnt 活性,通过增加胆固醇酯化和脂滴积累破坏胆固醇稳态,具有抗肿瘤活性。
    • 待询
    10-14周
    规格
    数量
  • Phenochalasin A
    TN10925253129-68-9
    Phenochalasin A (低于 20 μM) 能减少巨噬细胞内脂滴的数量和大小,并且没有表现出细胞毒性。
    • 待询
    10-14周
    规格
    数量
  • Dodoviscin A
    TN38821372527-25-7
    Dodoviscin A may be a new promising pigmentation-altering agent for cosmetic and therapeutic applications, it can inhibit melanin biosynthesis induced by 3-isobutyl-1-methylxanthine and PD98059.Dodoviscin A can promote adipocyte differentiation as charact
    • ¥ 4890
    待询
    规格
    数量
  • HBpep-SA acetate
    TP2797
    HBpep-SA acetate是一种细胞膜可渗透的多肽聚集体,它能在pH值低于6.5的酸性环境中相分离并形成稳定的液滴,从而高效递送生物大分子(如治疗肽和酶)和作为基于mRNA的疫苗载体。
    • ¥ 2230
    In stock
    规格
    数量
没有更多数据了